We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




AI Holography System Accurately Checks Quality of Red Blood Cells

By LabMedica International staff writers
Posted on 15 Aug 2022

Red blood cells are a major component of blood that carries oxygen. More...

Red blood cells collected through blood donation are stored for a certain period of time until they are used for transfusion when needed. This process is necessary because unhealthy red blood cells do not function properly and may lead to fatal side effects such as acute lung damage. Conventionally, image-based red blood cell analysis technology is used, which is an invasive method that destroys the three-dimensional structure of red blood cells as red blood cells are observed after staining. In addition, there are technical limitations in rapidly analyzing state changes such as three-dimensional shape, density change, and motility characteristics of red blood cells. To overcome this problem, a research team has developed an AI holography system that automatically extracts important information and inspects the quality of red blood cells. The new system is expected to become a key technology for enabling cleaner and healthier red blood cell injections to patients through accurate quality inspection of red blood cells stored for a certain period of time for blood transfusion.

Scientists at Daegu Gyeongbuk Institute of Science and Technology (DGIST, Daegu, Korea) had earlier developed 'holography-based red blood cell division and classification technology.' However, this requires a number of pre-processing algorithms before analysis, which takes a long time, and involves difficulties in performing accurate analysis and classification. In response, the team successfully developed an AI holography system that automatically inspects the quality of red blood cells stored for a certain time by combining the 3D structure image data of red blood cells obtained with holography technology and generative adversarial neural network technology.

If the developed technology is used, it will be possible to automatically extract important values ​​of judgment for red blood cells by applying the automatic red blood cell 3D structural image analysis algorithm and also check its quality. In particular, it is possible to test the quality of red blood cells precisely and simply as there is no need for invasive methods or pre-treatment procedures required by existing technologies. It is expected to be used as a core technology to help minimize the side effects of transfusion by injecting clean and healthy red blood cells to patients needing blood transfusions.

“The technology developed through this research is the source technology that can automatically analyze how red blood cells, stored for transfusion, change their three-dimensional shape depending on the storage period and determine whether stored red blood cells are healthy red blood cells that can be transfused,” said Professor Moon In-kyu of the Department of Robotics and Mechatronics Engineering at DGIST who led the research team. “It is expected that it will help minimize the occurrence of side effects after transfusion in the future as it can check the state of stored red blood cells more minutely and test whether the red blood cells are safe for the patient before transfusion.”

Related Links:
DGIST 


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Serological Pipet Controller
PIPETBOY GENIUS
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.